- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05082246
Impact of Complimentary and Alternative Practices on Patient Wellbeing During Rehabilitation
The study's objective is to assess whether CAM methods are feasible and beneficial in the WSRH setting; to assess stress (using the Perceived Stress Scale-14 and using BioSquares™), anxiety (using the Generalized Anxiety Disorder-7 scale), depression (using the Patient Health Questionnaire-9 scale), pain (using the Wong-Baker FACES scale), and vital signs using a multidisciplinary complementary approach with Heartfulness Meditation, Conscious Breathing, and Emotional Freedom Technique - the CAM practices for this study; and, to assess and compare the above scores for each participant just prior to and immediately after each treatment session.
The study hypothesizes that using CAM modalities in the WSRH is both feasible and beneficial in that patient population; the patients receiving the CAM modalities of treatment will show an improvement in the above-mentioned scores compared to participant scores prior to the intervention; and there may also be an improvement in patients' vital signs following the intervention of CAM practices.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute inpatient rehabilitation programs mainly focus on improving the physical wellbeing of the patients with physical and occupational therapies. While these may also have an impact on the mental and emotional wellbeing of the patients, there is not much available as therapies for mental and emotional wellbeing in these patients. In this study, the investigators wish to assess the impact of a structured CAM model practice for patients in rehabilitation program. These services will be offered through trained professionals. Depression and anxiety, stress, sleep, vital signs such as heart rate, blood pressure and pain scores will be studied within the period of study.
The study's objective is to assess whether CAM methods are feasible and beneficial in the WSRH setting; to assess stress (using the Perceived Stress Scale-14 and using BioSquares™), anxiety (using the Generalized Anxiety Disorder-7 scale), depression (using the Patient Health Questionnaire-9 scale), pain (using the Wong-Baker FACES scale), and vital signs using a multidisciplinary complementary approach with Heartfulness Meditation, Conscious Breathing, and Emotional Freedom Technique - the CAM practices for this study; and, to assess and compare the above scores for each participant just prior to and immediately after each treatment session.
The study hypothesizes that using CAM modalities in the WSRH is both feasible and beneficial in that patient population; the patients receiving the CAM modalities of treatment will show an improvement in the above-mentioned scores compared to participant scores prior to the intervention; and there may also be an improvement in patients' vital signs following the intervention of CAM practices.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mihir Modi, DO
- Phone Number: 717-851-1300
- Email: mmodi@wellspan.org
Study Contact Backup
- Name: Teresa Greco, MSN
- Phone Number: 717-846-6890
- Email: tgreco2.wellspan@gmail.com
Study Locations
-
-
Pennsylvania
-
York, Pennsylvania, United States, 17043
- Recruiting
- Wellspan Surgery and Rehabilitation Hospital
-
Contact:
- Mihir Modi, DO
- Phone Number: 717-851-1300
- Email: mmodi@wellspan.org
-
Contact:
- Teresa Greco, MSN
- Phone Number: 717-318-6761
- Email: tgreco2.wellspan@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meets age requirement
- Willing to participate
Exclusion Criteria:
- Patients who are unwilling to participate in the study will be excluded.
- Patients who are unable to sit for 30 minutes due to either physical or mental conditions will be excluded.
- Patients with an active diagnosis or history of bipolar disorder, schizophrenia or post-traumatic stress disorder (PTSD), as determined by the WSRH physiatrists or psychologists will be excluded.
- Patients with active suicidal thoughts and who are being referred for mental health help will also be excluded.
- Patients with a Montreal Cognitive Assessment (MOCA) greater than 20 will be excluded.
- Patients will be excluded who have a history of schizophrenia, schizoaffective disorder, or other primary psychotic disorder, or dysthymia with onset before age 20; current substance use or abuse disorder, eating disorder, obsessive compulsive disorder (OCD), bipolar disorder, acute psychosis, schizophrenia or schizoaffective disorder, cognitive disorder, organic brain damage or mental disorder, pervasive developmental disorder, mental retardation, borderline personality disorder, persistent antisocial behavior, a primary diagnosis of a personality disorder or risk of suicide, chronic depression/dysthymia, major depressive episode, depression secondary to a concurrent medical disorder, and clinically relevant neurological/ somatic illness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Pre- and Post- Intervention
Data will be gathered in participants with pre-intervention and post-intervention comparison.
|
During the Conscious Breathing session, participants will be asked to sit comfortably and with gently closed eyes.
Participants will be guided through several different kinds of breathing techniques, where the will focus will be on the expansion of the chest or abdomen, releasing all tension from the body, and visualizing breathing light into the body.
During the Heartfulness Meditation session, participants will be asked to sit comfortably and with gently closed eyes.
Starting with the feet and working towards the head, participants will be asked to relax each part of the body.
Then participants will focus on the heart and imagine it filled with light and love.
Participants will sit in this relaxed state for a few minutes to allow all stress and cares to be released.
During the Emotional Freedom Technique session, participants will be asked to tap lightly on several acupressure points while saying a variety of statements regarding pain, anxiety, depression or stress.
As participants tap on the acupressure points, participants will repeat phrases of affirmation and acceptance, and also talk through how pain, anxiety, depression or stress may cause distress but can learn to release these feelings.
participants will be given a picture of where each of the acupressure points lie on the face, chest or head, and will also be given a script of what to say while tapping on each acupressure point.
In addition, participants will be given a description of what each acupressure point "means" - its associated organ and what emotion that point helps to release.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in anxiety
Time Frame: Through completion of study, approximately 8 weeks
|
Measurement of anxiety using the Generalized Anxiety Disorder-7 scale.
The GAD-7 total score for the seven items ranges from 0 to 21, with 0 to 4 indicating minimal anxiety, 5 to 9 indicating mild anxiety, 10 to 14 indicating moderate anxiety, and 15 to 21 indicating severe anxiety
|
Through completion of study, approximately 8 weeks
|
|
Improvement in depression
Time Frame: Through completion of study, approximately 8 weeks
|
Measurement of depression using the Patient Health Questionnaire-9.
PHQ-9 total score for the seven items ranges from 0 to 27, with 1 to 4 indicating minimal depression, 5 to 9 indicating mild depression, 10 to 14 indicating moderate depression, 15 to 19 indicating moderately severe depression, and 20 to 27 indicating severe depression.
|
Through completion of study, approximately 8 weeks
|
|
Improvement in perceived stress
Time Frame: Through completion of study, approximately 8 weeks
|
Measurement of perceived stress using Perceived Stress Scale 14 can range from 0 to 40 with higher scores indicating higher perceived stress.
Scores ranging from 0-13 would be considered low stress; scores ranging from 14-26 would be considered moderate stress; and scores ranging from 27-40 would be considered high perceived stress.
|
Through completion of study, approximately 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in heart rate
Time Frame: Day of intervention, approximately 6 hours
|
Measurement of heart rate using pulse oximetry device.
|
Day of intervention, approximately 6 hours
|
|
Improvement in blood pressure
Time Frame: Day of intervention, approximately 6 hours
|
Measurement of blood pressure using DynaMap device.
|
Day of intervention, approximately 6 hours
|
|
Improvement in skin temperature
Time Frame: Day of intervention, approximately 6 hours
|
Measurement of skin temperature using BioSquares™.
These adhesive squares are placed on the webbing of participants' skin between the thumb and forefinger.
Skin temperature will change the color of the square.
Black is temperature of 79 degrees Fahrenheit and indicates tenseness.
Red is temperature of 74 degrees Fahrenheit and indicates nervousness.
Green is temperature of 87 degrees Fahrenheit and indicates calmness.
Blue is temperature of 791 degrees Fahrenheit and indicates a relaxed state.
|
Day of intervention, approximately 6 hours
|
|
Improvement in pain level
Time Frame: Day of intervention, approximately 6 hours
|
Measurement of pain using Wong-Baker FACES scale.
"No Hurt" is a pain score of zero.
"Hurts Little Bit" is a pain score of two.
"Hurts Little More" is a pain score of four.
"Hurts Even More" is a pain score of six.
"Hurts Whole Lot" is a pain score of eight.
"Hurts Worst" is a pain score of ten.
Each rating has a correlating facial expression.
|
Day of intervention, approximately 6 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mihir Modi, DO, WellSpan Health
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1659000
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Conscious Breathing
-
Adana City Training and Research HospitalCompletedSleep | Anxiety State | Fibromyalgia Syndrome | Female Sexual Dysfunction (FSD) | Fibromyalgia Impact Questionnaire | Breathing Pattern DisorderTurkey
-
Universidad Autónoma del Estado de HidalgoCompletedAnxiety | Pain Management | Patient Satisfaction | Virtual Reality | Pain Measurement | Breathing ExercisesMexico
-
University of SussexDMT Quest; ResearchHubCompletedWellbeing | Altered States of ConsciousnessUnited Kingdom
-
National Taiwan University HospitalCompleted
-
Beijing 302 HospitalRecruitingEndoscopic Retrograde Cholangiopancreatography | Procedural Pain | Sedation-related Complications | Conscious Sedation Adverse EventChina
-
University of BergenModum BadEnrolling by invitation
-
Singapore General HospitalMinistry of Health, SingaporeCompleted
-
Laval UniversityCanadian Foundation for Dietetic Research (CFDR)Completed
-
Kafkas UniversityNot yet recruitingMental Health IssueTurkey
-
Richard BlakeCompleted